Clinical trials
Frailty trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 3 |
| 2019 | 5 |
| 2020 | 5 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
| Unknown status | 8 |
| Recruiting | 4 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Charite University, Berlin, Germany | 9 |
| University of Erlangen-Nürnberg Medical School | 4 |
| Universitätsklinikum Hamburg-Eppendorf | 3 |
| Technical University of Munich | 2 |
| German Heart Institute | 1 |
| GlaxoSmithKline | 1 |
| Heinrich-Heine University, Duesseldorf | 1 |
| Helios University Hospital Wuppertal | 1 |
| Klaus Kenn | 1 |
| RWTH Aachen University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Frailty | 33 |
| Sarcopenia | 6 |
| Malnutrition | 3 |
| Postoperative Complications | 3 |
| Critical Illness | 2 |
| Pulmonary Disease, Chronic Obstructive | 2 |
| Stroke | 2 |
| Aortic Valve Stenosis | 1 |
| Bone Diseases, Metabolic | 1 |
| Cardio-Renal Syndrome | 1 |
Trials
Showing 76 to 33 of 33. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.